Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Sunday, December 6 2009 4:58am ET - U.S. Markets Closed.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > Akorn, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Akorn, Inc. Company Profile
Akorn works hard to grow roots in several segments of the pharmaceutical industry. The company makes and sells specialty therapeutic and diagnostic pharmaceuticals in categories including ophthalmology, rheumatology, and anesthesia. Akorn's ophthalmic segment includes antibiotics, glaucoma treatments, lubricating ointments, diagnostic stains and dyes, and contact lens accessories. The firm's injectable segment includes drugs for rheumatoid arthritis and pain management. Akorn's products are sold nationally to hospitals, physicians, pharmacies, and wholesalers. Akorn also provides contract manufacturing services for other drugmakers. Chairman John Kapoor controls about a third of the company.
Headlines for Akorn, Inc.
[external] 3 Stocks Springing Back
at Motley Fool - Fri Nov 27
AKORN INC Financials
EDGAR Online Financials - Fri Nov 13
New Star Analyst Rankings for Akorn, Inc.
StarMine - Wed Nov 11
AKORN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online - Tue Nov 10
More Headlines...
More on Akorn, Inc.
Quote Insider
Profile Financials
Reports Analyst Ratings
Research    
Contact Information
Address: 1925 West Field Court, Suite 300
Lake Forest, IL 60045
Phone:847-279-6100
Fax:800-943-3694
Financial Highlights
Fiscal Year End:December
Revenue (2008):93.60 M
Revenue Growth (1 yr):77.00%
Employees (2008):351
Employee Growth (1 yr):(-3.60%)
Key People
Chairman: John N. Kapoor
Interim CEO: Raj Rai
SVP Operations: Michael P. Stehn
Industry Information
Sector: Healthcare
Industry: Diagnostic Substances
Top Competitors
Alcon, Inc. (acl)
Hospira, Inc. (hsp)
Teva Pharmaceutical Industries Limited (teva)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?